INNT
TOTAL INVALIDATION PROCESSED BY THE IB
21/05/2026
Voltar para busca
Dado oficial do USPTO
OURLOOP
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
OURLOOP
ST13
US500000079198074Classe
5, 9, 10, 41, 42, 44
Pedido
79198074
Registro
5537615
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
62
Atualização mais recente
22/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10, 41, 42, 44
Data de depósito
06/07/2016
Data de registro
14/08/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/02/2025
Última transação
22/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
DK
Examinador
HENRY, NAKIA D
Unidade examinadora
O20
Localização atual
TMO LAW OFFICE 129 - EXAMINING ATTORNEY ASSIGNED
Titulares e representantes
Titulares
M. A. (pessoa física)
H. Lundbeck A/S
Representantes
Claudia A. Smith WHITE & CASE LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorderstrokedepressioncognitive impairmentmood disorderspsychosisanxietyepilepsysclerosisporphyriaHuntington's disease and disorderinsomniaParkinson's disease and disorderschizophreniabipolar disorder and diseaseADHDcancerpainalcoholism and dependency; diagnostic preparationssubstancesreagents and agents for medical purposes; pharmaceuticals for treatment of cognitive disorders
Classe 9
Downloadable electronic publications in the nature of booksreportsbrochuresbookletsleafletspatient information leafletsmagazinesjournalsteaching and educational material in the field of clinicalmedicalpharmaceutical or clinical or medical diagnostic research and developmentclinical testsclinical or medical diagnosticmedicinepharmaceuticalsmedical disordersmedical diseasesclinical or medical treatment and prevention; application software for mobile devices for clinical or medical diagnostic purposes relating to mental or behavioral health; downloadable electronic publications in the nature of brochuresbooksmagazines related to assessment of cognitive functions; applications software for mobile devices for assessment of cognitive functions; downloadable software for assessment of cognitive functions; software application for measuring psychical and mental health; software used as an installation tool for software applications to retrieve data which is sent automatically
Classe 10
Surgical and medical apparatus and instruments; diagnostic apparatus and instruments for medical purposes for monitoring patient behavior and medication compliance; integrated medical systems containing medical instruments and software for information and information management for use of a Web-based physical and psychological and neurological examination and assessment of patients and clients at a distance and at a clinic; medical instruments for informationguidance and control of medicines
Classe 41
Education in the nature classesseminarsworkshops in the field of clinicalmedicalpharmaceutical and medical diagnostic research and development; providing of training in the form of coursesseminarsworkshops in the field of clinicalmedicalpharmaceutical and medical diagnostic research and development; arranging and conducting seminarsconferencessymposiumsworkshops and courses in the field of clinicalmedicalpharmaceutical and medical diagnostic research and development; educational services in the nature of classesseminarsworkshopstraining services in the field of research and developmentscienceclinical testsdiagnosticmedicinepharmaceuticalsdisordersdiseasestreatment and prevention related to assessment of cognitive functions; providing the aforementioned services electronicallyon-linevia Internet or other electronic media; arranging and conducting expert in person educational forums in the field of clinicalmedicalpharmaceutical and medical diagnostic research and development; on-line training programs in the form of coursesseminarsworkshops in the field of research and developmentscienceclinical testsdiagnostic medicinepharmaceuticalswith regard to disordersdiseasestreatment and prevention related to assessment of cognitive functions; providing on-linenon-downloadable publicationsbooksreportsbrochuresbookletspatient information leafletsmagazinesjournalsteaching and educational material in the field of research and developmentscienceclinical testsdiagnostic medicinepharmaceuticals with regard to disordersdiseasestreatment and prevention related to assessment of cognitive functions
Classe 42
Pharmaceutical research and development; scientific and technological servicesresearch in the field of medical disordersmedical diseases and medical treatment; scientific and technological servicesresearch in the field of the central nervous system and related disordersdiseases and pharmaceuticals related thereto; medical research and tests in the field of assessment of cognitive functions for mental or behavioral ill health; clinical research and tests in the field of the assessment of cognitive functions; providing online non-downloadable screening software for assessment of cognitive functions
Classe 44
Medical and healthcare servicesproviding medical clinics providing assessment of cognitive functions and therapeutic servicesthe treatment of cognitive disorders and diseases; medical services in the field of psychiatry and psychology and diagnosis and treatment of central nervous system diseases and disorders; medical advice related to medical and pharmaceutical preparations and substances; healthcare and medical services related to central nervous system and brain disorders; providing medical and medicinal information in the field of diagnosticspharmaceuticalsdisordersdiseasestreatment and prevention; providing on-line medical data and analyses designed to provide patients with customized informationincluding information regarding medical dosediagnosistherapeutic issues; remote monitoring of data relating to patients health and diagnostics all offered via an Internet portal or an interactive platform
Publicações
Histórico de despachos e eventos da marca no USPTO.
62 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
02/05/2026
INPC
INVALIDATION PROCESSED
02/05/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
28/10/2025
C71T
CANCELLED SECTION 71
28/02/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
14/08/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/12/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/12/2018
FIMP
FINAL DISPOSITION PROCESSED
04/12/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
14/11/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
14/08/2018
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/06/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29/05/2018
PUBO
PUBLISHED FOR OPPOSITION
29/05/2018
GPNX
NOTIFICATION PROCESSED BY IB
25/05/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
16/05/2018
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
16/05/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/05/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/05/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/05/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
20/04/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/04/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/04/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/04/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/04/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/02/2018
GNRT
NON-FINAL ACTION E-MAILED
13/02/2018
CNRT
NON-FINAL ACTION WRITTEN
13/02/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/02/2018
GNRT
NON-FINAL ACTION E-MAILED
12/02/2018
CNRT
NON-FINAL ACTION WRITTEN
12/02/2018
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/02/2018
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
06/02/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/01/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/01/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/01/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/01/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
24/08/2017
GNRT
NON-FINAL ACTION E-MAILED
24/08/2017
CNRT
NON-FINAL ACTION WRITTEN
24/08/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
21/08/2017
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
08/08/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/07/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
24/07/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
24/07/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
24/07/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
24/07/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/07/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/07/2017
ALIE
ASSIGNED TO LIE
07/07/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/06/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/06/2017
RFNT
REFUSAL PROCESSED BY IB
08/04/2017
CHLD
CHANGE OF OWNER RECEIVED FROM IB
30/03/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
30/12/2016
RFRR
REFUSAL PROCESSED BY MPU
30/12/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
27/12/2016
CNRT
NON-FINAL ACTION WRITTEN
26/12/2016
MAFR
APPLICATION FILING RECEIPT MAILED
23/12/2016
DOCK
ASSIGNED TO EXAMINER
19/12/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/12/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
15/12/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace OURLOOP ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.